Overview

Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome

Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This prospective, randomized, controlled clinical trial will evaluate the effect and security of dexamethasone prevention for Patients of Ovarian Hyperstimulation Syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
BB 1101
Bromocriptine
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Endothelial Growth Factors